about
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that...
Read More
29.75
2.21
(8.02%)
851.3K
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Upstream Bio Inc is on 12 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Upstream Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..